908 Devices

Boston, United States Founded: 2012 • Age: 14 yrs
Handheld chemical detection devices are manufactured using mass spectrometry.
Request Access

About 908 Devices

908 Devices is a company based in Boston (United States) founded in 2012.. 908 Devices has raised $68.22 million across 8 funding rounds from investors including SLB, Arch Venture Partners and Sands Capital Ventures. The company has 246 employees as of December 31, 2024. 908 Devices has completed 2 acquisitions, including RedWave Technology and TRACE Analytics. 908 Devices operates in a competitive market with competitors including Refeyn, Advion, Impedimed, Zeteo Tech and Rigaku, among others.

  • Headquarter Boston, United States
  • Employees 246 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name 908 Devices Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $59.63 M
    18.72
    as on Dec 31, 2024
  • Net Profit
    $-72.21 M
    -98.37
    as on Dec 31, 2024
  • EBITDA
    $-28.38 M
    29.07
    as on Dec 31, 2024
  • Total Equity Funding
    $68.22 M (USD)

    in 8 rounds

  • Latest Funding Round
    $17.5 M (USD), Series E

    Apr 26, 2019

  • Investors
    SLB

    & 10 more

  • Employee Count
    246

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of 908 Devices

908 Devices is a publicly listed company on the NASDAQ with ticker symbol MASS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: MASS . Sector: Health technology · USA
People of 908 Devices
Headcount 50-200
Employee Profiles 38
Board Members and Advisors 23
Employee Profiles
People
Henry Torres
Inside Sales Representative
People
Collin B.
Controller
People
Kristy Shaw
Human Resources Operations Manager
People
Kevin J. Knopp
CEO & Co-founder

Unlock access to complete

Board Members and Advisors
people
Mark Spoto
Director
people
Fenel Eloi
Director
people
Tony J. Hunt
Director
people
Elena Chernokalskaya
Advisor

Unlock access to complete

Funding Insights of 908 Devices

908 Devices has successfully raised a total of $68.22M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $17.5 million completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series E — $17.5M
  • First Round

    (17 Aug 2012)

  • Investors Count 11
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2019 Amount Series E - 908 Devices Valuation Northpond Ventures
Sep, 2018 Amount Series C - 908 Devices Valuation Tao Capital Partners
Jun, 2016 Amount Series C - 908 Devices Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in 908 Devices

908 Devices has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SLB, Arch Venture Partners and Sands Capital Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
Founded Year Domain Location
Venture capital firm focused on life science companies
Founded Year Domain Location
Multi-stage venture capital investments are made in US sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by 908 Devices

908 Devices has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include RedWave Technology and TRACE Analytics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of commercial security services
2004
Biosensors for online monitoring of biotechnology cultivation processes are developed.
2003
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - 908 Devices

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

908 Devices Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of 908 Devices

908 Devices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Refeyn, Advion, Impedimed, Zeteo Tech and Rigaku, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Single molecular mass measurement technology is developed for biomolecules.
domain founded_year HQ Location
Microfluidics and mass spectrometry products are provided for clinical research.
domain founded_year HQ Location
Technologies for non-invasive fluid status assessment and monitoring are developed.
domain founded_year HQ Location
Biological mass spectrometers are manufactured for airborne microbe detection.
domain founded_year HQ Location
XRD, XRF, SAXS, Raman, metrology, and crystallography solutions are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about 908 Devices

When was 908 Devices founded?

908 Devices was founded in 2012.

Where is 908 Devices located?

908 Devices is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Is 908 Devices a funded company?

908 Devices is a funded company, having raised a total of $68.22M across 8 funding rounds to date.

How many employees does 908 Devices have?

As of Dec 31, 2024, the latest employee count at 908 Devices is 246.

What is the annual revenue of 908 Devices?

Annual revenue of 908 Devices is $59.63M as on Dec 31, 2024.

What does 908 Devices do?

908 Devices was founded in 2012 in Boston, United States, within the biotechnology and chemical analysis sector. Battery-operated, handheld detection tools and personal analyzers are produced for use by biologists and chemists. Mass spectrometry technology is employed in product development for applications including safety and security, food science, biotechnology, clinical diagnostics, and industrial process control. Operations focus on portable solutions for laboratory and field-based chemical analysis.

Who are the top competitors of 908 Devices?

908 Devices's top competitors include Refeyn, Impedimed and Advion.

Is 908 Devices publicly traded?

Yes, 908 Devices is publicly traded on NASDAQ under the ticker symbol MASS.

How many acquisitions has 908 Devices made?

908 Devices has made 2 acquisitions, including RedWave Technology, and TRACE Analytics.

Who are 908 Devices's investors?

908 Devices has 11 investors. Key investors include SLB, Arch Venture Partners, Sands Capital Ventures, Razor's Edge Ventures, and Tao Capital Partners.

What is 908 Devices's ticker symbol?

The ticker symbol of 908 Devices is MASS on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available